Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Medtronic
UBS
Johnson and Johnson
Accenture
Cerilliant
Baxter
Federal Trade Commission
QuintilesIMS

Generated: April 20, 2018

DrugPatentWatch Database Preview

TRIMETHOBENZAMIDE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Trimethobenzamide Hydrochloride, and what generic alternatives are available?

Trimethobenzamide Hydrochloride is a drug marketed by Gavis Pharms, Sun Pharm Industries, Hospira, Luitpold, Smith And Nephew, Solopak, and Watson Labs. and is included in ten NDAs.

The generic ingredient in TRIMETHOBENZAMIDE HYDROCHLORIDE is trimethobenzamide hydrochloride. There are six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the trimethobenzamide hydrochloride profile page.
Drug patent expirations by year for TRIMETHOBENZAMIDE HYDROCHLORIDE
Pharmacology for TRIMETHOBENZAMIDE HYDROCHLORIDE
Drug ClassAntiemetic
Physiological EffectEmesis Suppression
Synonyms for TRIMETHOBENZAMIDE HYDROCHLORIDE
138-56-7 (Parent)
4-(2-Dimethylaminoethoxy)-N-(3,4,5-trimethoxybenzoyl)benzylamine hydrochloride
4-[(2-Dimethylamino)ethoxy]-N-(3,5-trimethoxybenzoyl)benzylamine hydrochloride
554-92-7
554T927
AC1L29MV
AC1Q3DTA
AK140655
AKOS022172835
Ametik hydrochloride
Anaus
AX8155412
Benzamide, N-((4-(2-(dimethylamino)ethoxy)phenyl)methyl)-3,4,5-trimethoxy-, monohydrochloride
Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, hydrochloride
Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride
Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, monohydrochloride (8CI)
Benzamide,4,5-trimethoxy-, hydrochloride
Benzamide,4,5-trimethoxy-, monohydrochloride
C-46072
C21H28N2O5.HCl
CAS-554-92-7
CCG-40276
CHEMBL1200887
CS-7696
D02733
DSSTox_CID_27754
DSSTox_GSID_47774
DSSTox_RID_82531
DTXSID7047774
EINECS 209-075-6
FT-0736653
HMS1568O21
HMS1921G21
HY-12751A
Ibikin
LS-26624
MCULE-6632962832
MLS002154193
N-({4-[2-(dimethylamino)ethoxy]phenyl}methyl)(3,4,5-trimethoxyphenyl)carboxami de, chloride
N-(4-(2-(Dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxybenzamide hydrochloride
N-(p-(2-(Dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxybenzamide hydrochloride
N-(p-(2-(Dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxybenzamide monohydrochloride
N-[[4-(2-dimethylaminoethyloxy)phenyl]methyl]-3,4,5-trimethoxybenzamide hydrochloride
N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxybenzamide;hydrochloride
N-[4-[2-(Dimethylamino)ethoxy]benzyl]-3,4,5-trimethoxybenzamide Hydrochloride
N-[p-[2-(Dimethylamino)ethoxy]benzyl]-3,5-trimethoxybenzamide hydrochloride
n-{4-[2-(dim |thylamino) |thoxy]benzyl}-3,4,5-trim |thoxybenzamide chlorhydrate
Nauseton
NCGC00016509-01
NCGC00016509-06
NCGC00094803-01
NCGC00094803-02
NSC 37882
NSC-37882
NSC-757359
NSC37882
NSC757359
Pharmakon1600-01500594
Poligerim
Prestwick_526
Ro 2-9578
SBB058189
SCHEMBL41339
SMR001233483
SPECTRUM1500594
ST24048359
ST51015132
T-Gen
Tebamide
Ticon
Tigan
Tox21_110465
Tox21_110465_1
Trimethobenzamide HCL
Trimethobenzamide hydrochloride (USP)
Trimethobenzamide hydrochloride [USP]
trimethobenzamide monohydrochloride
TRIMETHOBENZAMIDEHYDROCHLORIDE
UNII-WDQ5P1SX7Q
V1615
WDQ5P1SX7Q
WLN: 1OR BO1 CO1 EVM1R DO2N1&1 &GH

US Patents and Regulatory Information for TRIMETHOBENZAMIDE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gavis Pharms TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride CAPSULE;ORAL 076546-001 Aug 20, 2003 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Solopak TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride INJECTABLE;INJECTION 089094-001 Apr 4, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride INJECTABLE;INJECTION 091330-001 Mar 8, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride INJECTABLE;INJECTION 086577-001 Oct 19, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Accenture
Mallinckrodt
US Department of Justice
Colorcon
Chubb
Covington
Deloitte
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.